Literature DB >> 24030395

Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibition.

Jianli Zhao1, Feng Wang, Yanqing Zhang, Liyuan Jiao, Wayne Bond Lau, Lili Wang, Baojiang Liu, Erhe Gao, Walter J Koch, Xin-Liang Ma, Yajing Wang.   

Abstract

BACKGROUND: The inhaled anesthetic sevoflurane has been demonstrated to protect against myocardial ischemia/reperfusion (MI/R) injury via mechanisms involving AMP-activated protein kinase (AMPK) and caveolin-3 (Cav-3). However, the relative contributions of AMPK and Cav-3 to sevoflurane preconditioning (SF-PreCon)-mediated cardioprotection and their precise underlying mechanisms of action remain incompletely understood. METHODS AND
RESULTS: SF-PreCon (consisting of 3 cycles of 15-minute exposure to 2% sevoflurane before 30 minutes of MI) decreased MI/R injury in wild-type mice (caspase-3 activity, -29.1%; infarct size, -20.2%; and left ventricular end diastolic pressure, -33.8%). In cardiac-specific AMPKα2 dominant-negative overexpressing mice, the cardioprotective effect of SF-PreCon was largely retained (caspase-3 activity, -26.7%; infarct size, -16.7%; and left ventricular end-diastolic pressure, -25.9%; P<0.01). In contrast, SF-PreCon failed to significantly protect Cav-3 knockout mice against MI/R injury (P>0.05). SF-PreCon significantly decreased MI/R-induced superoxide generation in wild-type (-43.6%) and AMPK dominant-negative overexpressing mice (-35.5%; P<0.01) but not in Cav-3 knockout mice. SF-PreCon did not affect nicotinamide adenine dinucleotide phosphate oxidase expression but significantly inhibited cyclooxygenase-2 expression in wild-type (-38.7%) and AMPK dominant-negative overexpressing mice (-35.8%) but not in Cav-3 knockout mice.
CONCLUSIONS: We demonstrate for the first time SF-PreCon mediates cardioprotection against MI/R injury via caveolin-3-dependent cyclooxygenase-2 inhibition and antioxidative effects.

Entities:  

Keywords:  caveolin; preconditioning; reperfusion injury; signal transduction

Mesh:

Substances:

Year:  2013        PMID: 24030395      PMCID: PMC3884906          DOI: 10.1161/CIRCULATIONAHA.112.000045

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  21 in total

Review 1.  Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation.

Authors:  John H Chidlow; William C Sessa
Journal:  Cardiovasc Res       Date:  2010-03-03       Impact factor: 10.787

2.  Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.

Authors:  Yasuo M Tsutsumi; Yoshitaka Kawaraguchi; Yousuke T Horikawa; Ingrid R Niesman; Michael W Kidd; Blake Chin-Lee; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

3.  Sevoflurane pre- and post-conditioning protect the brain via the mitochondrial K ATP channel.

Authors:  S Adamczyk; E Robin; M Simerabet; E Kipnis; B Tavernier; B Vallet; R Bordet; G Lebuffe
Journal:  Br J Anaesth       Date:  2010-02       Impact factor: 9.166

4.  Differences in production of reactive oxygen species and mitochondrial uncoupling as events in the preconditioning signaling cascade between desflurane and sevoflurane.

Authors:  Filip Sedlic; Danijel Pravdic; Marko Ljubkovic; Jasna Marinovic; Anna Stadnicka; Zeljko J Bosnjak
Journal:  Anesth Analg       Date:  2009-08       Impact factor: 5.108

5.  Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.

Authors:  Ling Tao; Yajing Wang; Erhe Gao; Hangxiang Zhang; Yuexing Yuan; Wayne B Lau; Lawrence Chan; Walter J Koch; Xin L Ma
Journal:  Circ Res       Date:  2009-11-25       Impact factor: 17.367

6.  Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting.

Authors:  T Hemmerling; J-F Olivier; N Le; I Prieto; D Bracco
Journal:  Eur J Anaesthesiol       Date:  2007-09-26       Impact factor: 4.330

7.  Reactive oxygen species-induced stimulation of 5'AMP-activated protein kinase mediates sevoflurane-induced cardioprotection.

Authors:  Regis R Lamberts; Geert Onderwater; Nazha Hamdani; M Jumoke A Vreden; Jeroen Steenhuisen; Etto C Eringa; Stephan A Loer; Ger J M Stienen; R Arthur Bouwman
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

8.  Cardiac-specific overexpression of caveolin-3 induces endogenous cardiac protection by mimicking ischemic preconditioning.

Authors:  Yasuo M Tsutsumi; Yousuke T Horikawa; Michelle M Jennings; Michael W Kidd; Ingrid R Niesman; Utako Yokoyama; Brian P Head; Yasuko Hagiwara; Yoshihiro Ishikawa; Atsushi Miyanohara; Piyush M Patel; Paul A Insel; Hemal H Patel; David M Roth
Journal:  Circulation       Date:  2008-10-20       Impact factor: 29.690

9.  Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action.

Authors:  Yajing Wang; Ling Tao; Yuexin Yuan; Wayne Bond Lau; Rong Li; Bernard L Lopez; Theodore A Christopher; Rong Tian; Xin-Liang Ma
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-26       Impact factor: 4.310

10.  A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse.

Authors:  Erhe Gao; Yong Hong Lei; Xiying Shang; Z Maggie Huang; Lin Zuo; Matthieu Boucher; Qian Fan; J Kurt Chuprun; Xin L Ma; Walter J Koch
Journal:  Circ Res       Date:  2010-10-21       Impact factor: 17.367

View more
  21 in total

1.  A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin, activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy.

Authors:  Jeffrey E Cohen; Brendan P Purcell; John W MacArthur; Anbin Mu; Yasuhiro Shudo; Jay B Patel; Christopher M Brusalis; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; Mollie S Davis; George Hung; William Hiesinger; Pavan Atluri; Kenneth B Margulies; Jason A Burdick; Y Joseph Woo
Journal:  Circ Heart Fail       Date:  2014-06-05       Impact factor: 8.790

2.  Sevoflurane attenuates cardiomyocyte apoptosis by mediating the miR-219a/AIM2/TLR4/MyD88 axis in myocardial ischemia/reperfusion injury in mice.

Authors:  Yan Li; Na Xing; Jingjing Yuan; Jianjun Yang
Journal:  Cell Cycle       Date:  2020-05-23       Impact factor: 4.534

3.  Caveolin-3 plays a critical role in autophagy after ischemia-reperfusion.

Authors:  Adam Kassan; Uyen Pham; Quynhmy Nguyen; Melissa E Reichelt; Eunbyul Cho; Piyush M Patel; David M Roth; Brian P Head; Hemal H Patel
Journal:  Am J Physiol Cell Physiol       Date:  2016-10-05       Impact factor: 4.249

4.  Sevoflurane preconditioning in on-pump coronary artery bypass grafting: a meta-analysis of randomized controlled trials.

Authors:  Yan Lu; Liwei Wang; Na Liu; Tianxin Dong; Ruhong Li
Journal:  J Anesth       Date:  2016-08-16       Impact factor: 2.078

5.  The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model.

Authors:  Jugajyoti Baruah; Ryan Hitzman; Jane Zhang; Suhnrita Chaudhuri; Victoria Mastej; Kishore K Wary
Journal:  J Biol Chem       Date:  2017-10-25       Impact factor: 5.157

6.  Sevoflurane Promotes Bactericidal Properties of Macrophages through Enhanced Inducible Nitric Oxide Synthase Expression in Male Mice.

Authors:  Thomas J Gerber; Valérie C O Fehr; Suellen D S Oliveira; Guochang Hu; Randal Dull; Marcelo G Bonini; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Anesthesiology       Date:  2019-12       Impact factor: 7.892

7.  Sevoflurane ameliorates intestinal ischemia-reperfusion-induced lung injury by inhibiting the synergistic action between mast cell activation and oxidative stress.

Authors:  Chenfang Luo; Dongdong Yuan; Weicheng Zhao; Huixin Chen; Gangjian Luo; Guangjie Su; Ziqing Hei
Journal:  Mol Med Rep       Date:  2015-03-23       Impact factor: 2.952

8.  Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signaling.

Authors:  Jing Zhang; Chen Wang; Shuchun Yu; Zhenzhong Luo; Yong Chen; Qin Liu; Fuzhou Hua; Guohai Xu; Peng Yu
Journal:  Sci Rep       Date:  2014-12-04       Impact factor: 4.379

Review 9.  Peri-operative anaesthetic myocardial preconditioning and protection - cellular mechanisms and clinical relevance in cardiac anaesthesia.

Authors:  G Kunst; A A Klein
Journal:  Anaesthesia       Date:  2015-04       Impact factor: 6.955

10.  Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery.

Authors:  Xiao Liu; Xiaopeng Liu; Ruike Wang; Hui Luo; Gang Qin; L U Wang; Zhi Ye; Qulian Guo; E Wang
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.